
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the classification of leukemia after occupational radiation (not 'post cytotoxic therapy' under WHO 2022), the choice of azacitidine with venetoclax over intensive induction, the venetoclax dose with posaconazole, the transfusion thresholds, and the transplant and palliative care plans. | ||
| provenance review | not_started | Nobel biography, AtomicArchive, the Atomic Heritage Foundation profile, the Linda Hall Library, Smithsonian, an INCOIS course page, and the AIP exhibit logged. Britannica and Wikipedia were not used. The year her tuberculosis began and the dates of her 1956 mountain stay are not documented in the fetched sources. | ||
| safe messaging review | not_started | Her mother is never named in this record. Her children are not named. No sensitive claims. Her death is recorded as history in one sentence. Prognosis is discussed in the modern episode in plain terms. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-10-19 Progress note 05 (C-CDA) | Azole safety: posaconazole interactions (venetoclax dose), liver tests, QTc, trough level | At start; liver tests weekly; trough level after about a week of dosing; QTc with any added QT-prolonging drug | Missed: the posaconazole trough level due after about a week of dosing was not drawn. No harm judging by the absence of fever or fungal infection, normal liver tests, and a QTc of 446 ms on day 11. Corrective action: trough level with the next blood count, and added to the cycle order set |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-09-16 Progress note 02 (C-CDA) | Examination | Fitness: performance status, comorbidity (HCT-CI), echocardiogram, lung function | Ordered | ECOG 1 two days ago; echocardiogram, ECG and lung function tests booked for the results review |
| 2026-10-26 Progress note 06 (C-CDA) | Prevention | COVID-19 vaccine | Ordered | This season's vaccine ordered for the next infusion visit |
| Claim | Statement | Certainty |
|---|---|---|
| CLM-0011 | Smithsonian magazine reported that the 1946 polonium accident is thought to have possibly been responsible for her death from leukemia ten years later, and that she may have been the first person to die of polonium poisoning. | possible |
| CLM-0012 | Her leukemia is usually attributed to over-exposure to X-rays during the First World War and to radioactive materials during her life of research. | probable |
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-09-14 | White cell count | 2.1 10*3/uL (low) | Low |
| 2026-09-14 | Absolute neutrophil count | 0.6 10*3/uL (low) | Low |
| 2026-09-14 | Hemoglobin | 8.4 g/dL (low) | Low |
| 2026-09-14 | MCV | 104 fL (high) | High |
| 2026-09-14 | Platelets | 38 10*3/uL (low) | Low |
| 2026-09-14 | Blood blasts (smear) | 12% (high) | High |
| 2026-09-14 | LDH | 412 U/L (high) | High |
| 2026-09-14 | Uric acid | 6.4 mg/dL (high) | High |
| 2026-09-16 | White cell count | 1.9 10*3/uL (low) | Low |
| 2026-09-16 | Absolute neutrophil count | 0.5 10*3/uL (low) | Low |
| 2026-09-16 | Hemoglobin | 7.1 g/dL (low) | Low |
| 2026-09-16 | Platelets | 22 10*3/uL (low) | Low |
| 2026-09-16 | Blood blasts (smear) | 14% (high) | High |
| 2026-09-16 | Bone marrow blasts | 34% (high) | High |
| 2026-09-28 | White cell count | 1.6 10*3/uL (low) | Low |
| 2026-09-28 | Absolute neutrophil count | 0.4 10*3/uL (low) | Low |
| 2026-09-28 | Hemoglobin | 8.6 g/dL (low) | Low |
| 2026-09-28 | Platelets | 18 10*3/uL (low) | Low |
| 2026-09-28 | Blood blasts (smear) | 16% (high) | High |
| 2026-09-28 | LDH | 448 U/L (high) | High |
| 2026-09-28 | DLCO, percent predicted | 58% (low) | Low |
| 2026-09-28 | FEV1, percent predicted | 76% (low) | Low |
| 2026-10-19 | White cell count | 0.6 10*3/uL (low) | Low |
| 2026-10-19 | Absolute neutrophil count | 0.2 10*3/uL (low) | Low |
| 2026-10-19 | Hemoglobin | 8.9 g/dL (low) | Low |
| 2026-10-19 | Platelets | 31 10*3/uL (low) | Low |
| 2026-10-30 | White cell count | 2.2 10*3/uL (low) | Low |
| 2026-10-30 | Absolute neutrophil count | 0.9 10*3/uL (low) | Low |
| 2026-10-30 | Hemoglobin | 9.6 g/dL (low) | Low |
| 2026-10-30 | Platelets | 88 10*3/uL (low) | Low |
| 2026-10-08 | White cell count | 0.7 10*3/uL (low) | Low |
| 2026-10-08 | Absolute neutrophil count | 0.1 10*3/uL (low) | Low |
| 2026-10-08 | Hemoglobin | 7.4 g/dL (low) | Low |
| 2026-10-08 | Platelets | 9 10*3/uL (low) | Low |
| 2026-10-08 | Potassium | 3.3 mmol/L (low) | Low |